Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

UPDATE: Covetrus Q2 Adj. EPS $0.26 Beats $0.25 Estimate, Sales $1.22B Miss $1.22B Estimate

Author: Benzinga Newsdesk | August 04, 2022 08:10am
Covetrus (NASDAQ:CVET) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.25 by 4 percent. This is unchanged from the same period last year. The company reported quarterly sales of $1.22 billion which missed the analyst consensus estimate of $1.22 billion by 0.25 percent. This is a 2.35 percent increase over sales of $1.19 billion the same period last year.

Posted In: CVET

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist